AU512931B2 - 13, 14-didehydro prostaglandin - Google Patents

13, 14-didehydro prostaglandin

Info

Publication number
AU512931B2
AU512931B2 AU21337/77A AU2133777A AU512931B2 AU 512931 B2 AU512931 B2 AU 512931B2 AU 21337/77 A AU21337/77 A AU 21337/77A AU 2133777 A AU2133777 A AU 2133777A AU 512931 B2 AU512931 B2 AU 512931B2
Authority
AU
Australia
Prior art keywords
didehydro
prostaglandin
didehydro prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU21337/77A
Other versions
AU2133777A (en
Inventor
H. W Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AU2133777A publication Critical patent/AU2133777A/en
Application granted granted Critical
Publication of AU512931B2 publication Critical patent/AU512931B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/19Acids containing three or more carbon atoms
    • C07C53/21Acids containing three or more carbon atoms containing fluorine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64Acyl halides
    • C07C57/72Acyl halides containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
AU21337/77A 1976-02-17 1977-01-14 13, 14-didehydro prostaglandin Expired AU512931B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65857476A 1976-02-17 1976-02-17
USUS658574 1976-02-17

Publications (2)

Publication Number Publication Date
AU2133777A AU2133777A (en) 1978-07-20
AU512931B2 true AU512931B2 (en) 1980-11-06

Family

ID=24641803

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21337/77A Expired AU512931B2 (en) 1976-02-17 1977-01-14 13, 14-didehydro prostaglandin

Country Status (7)

Country Link
JP (1) JPS6013034B2 (en)
AU (1) AU512931B2 (en)
BE (1) BE851358A (en)
CH (1) CH630897A5 (en)
DE (1) DE2704960A1 (en)
NL (1) NL7701624A (en)
ZA (1) ZA77159B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH053063Y2 (en) * 1986-12-13 1993-01-26
ES2099822T3 (en) * 1991-04-22 1997-06-01 Taisho Pharmaceutical Co Ltd PROSTAGLANDINE ANALOG E1.
JPH0884623A (en) * 1994-09-20 1996-04-02 Chitose Kk Desktop shelf
CN116425707A (en) * 2023-03-31 2023-07-14 南京华威医药科技集团有限公司 Tafluprost intermediate isomer impurity and preparation method thereof

Also Published As

Publication number Publication date
ZA77159B (en) 1977-11-30
DE2704960A1 (en) 1977-08-18
AU2133777A (en) 1978-07-20
BE851358A (en) 1977-08-11
JPS52100448A (en) 1977-08-23
JPS6013034B2 (en) 1985-04-04
NL7701624A (en) 1977-08-19
CH630897A5 (en) 1982-07-15

Similar Documents

Publication Publication Date Title
AU513281B2 (en) 3,7-disubstituted -3- cephem -4-carboxylic acid compounds
AU517020B2 (en) 10, 19-dihydro-vitamin d compounds
AU506818B2 (en) Prostaglandins
AU508007B2 (en) 1, 5-Disubstituted-2-Pyrrolidones
AU512404B2 (en) 2, 6-Methano-2H-l-Benzoxocins
AU508891B2 (en) 5,6-dihydro-prostacyclin analogs
AU500386B2 (en) 1,2,6-thidiazinones
AU515495B2 (en) 5, 5-trimethylhexanoyl-ferrocene
AU513812B2 (en) Substituted 2, 1, 3-benzothiadiazine compounds
AU511988B2 (en) O-ethyl-s-n-propyl-0,2,2,2-trihaloethy_phosphoro-thiolates/thionothiolates
AU505974B2 (en) 3', 4'-dideoxykanamcin b
AU512931B2 (en) 13, 14-didehydro prostaglandin
AU509971B2 (en) 13, 14-ethynyl Prostaglandin Analogues
AU507282B2 (en) 3, 3-Dimethylpent-4-Endic Acid
AU517895B2 (en) 1, 3-dihydro-1-dimethyl phosphinylalkyl 3 phenylspiro ( iosbenzofurn)s
AU514741B2 (en) 5,6-dehydropenicillins
AU496086B2 (en) Prostaglandin type 1, 15-lactones
AU524600B2 (en) 2,6-methano-3-benzazocines
AU521307B2 (en) Prostaglandin type compounds
AU496552B2 (en) Prostaglandin-type 1, 11-lactones
AU520088B2 (en) 1, 2, 3, 4-tetrahydro-naphthalenes
AU496088B2 (en) Prostaglandin-type 1, 9-lactones
AU514806B2 (en) 1, 3, 5-triazapenta-1, 4-diene-phosphorus derivatives
AU515307B2 (en) 1, 3-benzodioxine derivatives
AU496087B2 (en) Prostaglandin-type, 1, 15 lactones